Xinhua Silk Road: Financial Street Forum annual conference to be held on Oct. 27-30 in Beijing

BEIJING, Oct. 20, 2025 /PRNewswire/ — The annual conference of Financial Street…

Hindustan Zinc Achieves Highest Ever 2Q Revenue and EBITDA; PAT Surges 19% QoQ

UDAIPUR, India, Oct. 20, 2025 /PRNewswire/ — India based Hindustan Zinc Limited,…

Osier Belle: Sydney's Most Luxurious Outdoor Furniture Finds a New Home

Australia’s leading bespoke outdoor furniture brand opens an expansive new showroom in…

Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability

SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ — Antengene Corporation Limited…

Save Now, Travel through March: T'way Air Announces Fall Savings to Korea

Promo Code FLYOCT & Special Coupons for Travel through March 2026 TAIPEI, Oct.…

China's enduring commitment to peaceful development: a consistent path across past, present, and future

BEIJING, Oct. 20, 2025 /PRNewswire/ — A report from People’s Daily: Amid…

CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

SHANGHAI, Oct. 20, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:…

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity

–          The 12-week U.S. Phase IIa study is evaluating the efficacy, safety…